NEETPGAI
BlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pharmacology/Antifungals
    Antifungals
    hard
    pill Pharmacology

    A 58-year-old man with acute leukemia undergoing chemotherapy develops fever, cough, and bilateral pulmonary infiltrates. Chest imaging suggests possible invasive aspergillosis. Which investigation is most appropriate to confirm the diagnosis and initiate antifungal therapy?

    A. Serum IgG antibodies against Aspergillus fumigatus
    B. Sputum culture on Sabouraud dextrose agar
    C. Serum galactomannan antigen detection by ELISA
    D. Bronchoalveolar lavage (BAL) with galactomannan antigen and PCR for Aspergillus

    Explanation

    ## Diagnosis of Invasive Aspergillosis ### Clinical Context Invasive aspergillosis (IA) is a life-threatening opportunistic infection in severely immunocompromised patients (neutropenia, hematologic malignancy, transplant recipients). Rapid diagnosis is critical because mortality increases with treatment delay. ### Investigation of Choice: Bronchoalveolar Lavage (BAL) **Key Point:** BAL with combined galactomannan antigen detection and PCR is the gold standard for diagnosing invasive pulmonary aspergillosis when the clinical suspicion is high. ### Why BAL Is Superior | Feature | BAL | Serum Galactomannan | Sputum Culture | Serum IgG | |---------|-----|-------------------|-----------------|----------| | **Sensitivity** | 70–90% (with antigen + PCR) | 50–70% (variable) | 10–20% (poor) | Low in acute IA | | **Specificity** | High (>95%) | Moderate (85–90%) | Moderate | Not diagnostic of IA | | **Timing** | Direct sampling from site of infection | Indirect marker; delayed clearance | Colonization vs. infection unclear | Chronic/allergic aspergillosis | | **Clinical utility** | Confirms diagnosis + identifies organism | Supportive; not diagnostic alone | Colonization common; unreliable | Allergic bronchopulmonary aspergillosis | ### Diagnostic Algorithm ```mermaid flowchart TD A[Immunocompromised + Pulmonary infiltrates]:::outcome --> B{Clinical suspicion<br/>for IA high?}:::decision B -->|Yes| C[Perform BAL]:::action C --> D{Galactomannan<br/>antigen + PCR<br/>positive?}:::decision D -->|Yes| E[Invasive aspergillosis<br/>confirmed]:::outcome D -->|No| F[Repeat BAL or<br/>consider CT-guided biopsy]:::action B -->|Moderate| G[Serum galactomannan<br/>as adjunct]:::action G --> H{Positive?}:::decision H -->|Yes| I[High suspicion;<br/>proceed to BAL]:::action H -->|No| J[Low probability;<br/>consider alternatives]:::outcome ``` **High-Yield:** In immunocompromised patients with fever and pulmonary infiltrates, BAL is preferred over serum markers because it provides direct sampling from the site of infection, increasing diagnostic yield and allowing organism identification. ### Clinical Pearl **Tip:** Do not delay antifungal therapy (liposomal amphotericin B or voriconazole) while awaiting BAL results if clinical suspicion is very high (neutropenia + fever + infiltrates). Start empiric therapy and confirm diagnosis simultaneously. ### Why Serum Galactomannan Alone Is Insufficient - Sensitivity is 50–70% and varies by patient population - Antigen is cleared slowly; may be negative early in infection - Not diagnostic in isolation; requires clinical correlation - False positives occur with other molds and some bacterial infections ### Why Sputum Culture Is Inadequate - Aspergillus is a common environmental contaminant - Colonization vs. infection cannot be distinguished from culture alone - Sensitivity is only 10–20% in invasive IA - Takes 3–7 days for results ### Why Serum IgG Is Wrong - IgG antibodies develop in chronic/allergic aspergillosis, not acute invasive disease - Immunocompromised patients may not mount an antibody response - Not diagnostic for invasive aspergillosis

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pharmacology Questions